San Francisco Sentry Investment Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-8
Closed -$1K 1029
2018
Q3
$1K Buy
+8
New +$1K ﹤0.01% 856